Clinical Trials List
2025-10-28 - 2027-04-16
Phase III
Recruiting1
ICD-10D82.2
Immunodeficiency with short-limbed stature
ICD-10D82.3
Immunodeficiency following hereditary defective response to Epstein-Barr virus
ICD-10D82.4
Hyperimmunoglobulin E [IgE] syndrome
ICD-10D82.8
Immunodeficiency associated with other specified major defects
ICD-10D82.9
Immunodeficiency associated with major defect, unspecified
ICD-10D84.0
Lymphocyte function antigen-1 [LFA-1] defect
ICD-10D84.1
Defects in the complement system
ICD-10D89.3
Immune reconstitution syndrome
ICD-10D89.89
Other specified disorders involving the immune mechanism, not elsewhere classified
ICD-10M35.9
Systemic involvement of connective tissue, unspecified
ICD-9279.8
Other specified disorders involving the immune mechanism
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 許鶴忀 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- 洪維廷 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 林靖才 Division of Rheumatology
- 高宗楙 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
90 participants
